ApoAI deficiency results in marked reductions in plasma cholesterol but no alterations in amyloid-beta pathology in a mouse model of Alzheimer's disease-like cerebral amyloidosis.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples